about
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease...
Read More
1.19
-0.01
(-0.83%)
253.7K
XNYS Volume
XNYS 06 Oct, 2026 10:38 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Annovis Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..